ACTG vs BMRN · rev $168.8M vs P/E 40, rev $1.76B
Acacia Research Corporation (ACTG) versus Biomarin Pharmaceutical Inc (BMRN) — a side-by-side from cached financials, not a winner call.
Acacia Research Corporation (ACTG) is a business equipment & supplies company listed on NASDAQ.
Biomarin Pharmaceutical Inc (BMRN) is a biotechnology company listed on NASDAQ.
Latest reported ACTG revenue for 2026-06-30 was $168.8M. Net income was -$15.7M. ACTG currently screens at market cap $452.0M.
Latest reported BMRN revenue for 2026-06-30 was $1.76B. Net income was $150.3M. BMRN currently screens at market cap $10.63B and trailing P/E 39.6.
ACTG currently screens at market cap $452.0M. BMRN currently screens at market cap $10.63B and trailing P/E 39.6.
Not investment advice. Open the ACTG and BMRN stock pages for the full models.
Not investment advice.